We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Theravance, Viatris Sue to Block Copies of COPD Combination Product
Theravance, Viatris Sue to Block Copies of COPD Combination Product
Theravance Biopharma and Viatris have alleged that multiple competitors infringed on patent protections for Yupelri (revefenacin) — a combination drug-device product used to treat chronic obstructive pulmonary disease (COPD) — by developing generic versions.